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Abstract 
 
The accuracy of non-invasive blood pressure monitoring when compared to 
intra-arterial blood pressure monitoring in patients with severe pre-eclampsia 
during an acute hypertensive crisis 
 
Principal investigator: Dr Sangita Dalla 
Principal promoter: Dr Eduard Langenegger 
Co-promoter and Statistician: Dr Gregory Petro 
 
OBJECTIVE: The aim of this study was to compare the accuracy of non-invasive 
blood pressure measurements, using automated and manual devices, against 
invasive intra-arterial blood pressure measurements in patients with pre-eclampsia, 
during a hypertensive blood pressure peak. 
 
STUDY DESIGN: In this prospective study, women admitted to the Obstetrics Critical 
Care Unit, with confirmed pre-eclampsia and acute severe hypertension, who had an 
intra-arterial line in situ, were asked to participate. During an intra-arterial blood 
pressure peak, both an automated oscillometric and a blinded manual aneroid 
sphygmomanometric blood pressure was recorded. These two methods of blood 
pressure measurements were compared to intra-arterial blood pressure 
measurements. The accuracy of a mean arterial pressure (MAP) ≥ 125mmHg in 
detecting a systolic blood pressure (SBP) ≥ 160mmHg, using all three methods, was 
also determined. 
 
RESULTS: There was poor correlation between intra-arterial SBP and automated 
and manual SBP (r = 0.34, p < 0.01; r = 0.41, p < 0.01 respectively). The mean 
differences between automated and manual SBP compared to the intra-arterial SBP 
was 24 ± 17mmHg (p < 0.01) and 20 ± 15 mmHg (p < 0.01) respectively. There was 
better correlation between intra-arterial diastolic blood pressure (DBP) and 
automated and manual DBP (r = 0.61, p < 0.01; r = 0.59, p < 0.01 respectively). The 
mean differences of the automated and manual DBP was not statistically significant 
when compared to the intra-arterial DBP. There was poor correlation between the 
intra-arterial MAP and the automated MAP (r = 0.44, p < 0.01) and good correlation 
with the manual MAP (r = 0.56, p < 0.01). The mean differences of the automated 
and manual MAP were statistically significant (5 ± 13mmHg, p < 0.01; 8 ± 11mmHg, 
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p < 0.01 respectively). The sensitivity of automated and manual methods in detecting 
a SBP ≥ 160mmHg was 23.4% and 37.5% respectively. A MAP ≥ 125mmHg in 
detecting a SBP ≥ 160mmHg, when using intra-arterial, automated and manual 
methods of blood pressure measurements showed low sensitivity (35.9%, 21.9% and 
17.2% respectively). 
 
CONCLUSION: This study demonstrated that both the automated and manual 
methods of blood pressure measurements were not an accurate measure of the true 
systolic intra-arterial blood pressure, when managing pre-eclamptic patients with 
acute severe hypertension. In such situations, intra-arterial blood pressure monitoring 
should be used when possible. When this is not possible, manual aneroid 
sphygmomanometry is recommended. Underestimating blood pressure, particularly 
SBP, may lead to severe maternal morbidity and mortality. 
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Opsomming 
 
Die akuraatheid van nie indringende bloeddruk monitering wanneer dit 
vergelyk word met intra-arteriele bloed druk monitering in pasiente met pre-
eklampsie gedurende ‘n episode van ‘n akute hipertensiewe krisis 
 
Primêre navorser: Dr Sangita Dalla 
Promotor: Dr Eduard Langenegger 
Statistikus en mede-promotor: Dr Gregory Petro 
 
DOELWIT: Die doel van hierdie studie is om die akuraatheid van nie invasiewe 
bloeddruk metings, wanneer geneem met outomatiese en manuele aparate, te 
vergelyk met intra-arteriele bloed druk metings in pasiente met pre-eklampsie, 
gedurende ‘n hipertensiewe bloeddruk piek. 
 
STUDIE ONTWERP: In hierdie prospektiewe beskrywende dwarssnit studie, was 
pasiente wat toegelaat was tot die Obstetriese Kritieke Sorg Eenheid met pre-
eklampsie, akute erge hipertensie en ‘n intra-arteriele lyn in situ gevra om deel te 
neem. Gedurende ‘n intra-arteriele erge hipertensiewe piek is beide die outomatiese 
ossilometriese en die geblinde aneroide sfigmometer lesing neergeskryf. Hierdie 
twee metodes van non invasiewe bloed druk lesings is vergelyk met intra-arteriele 
bloed druk lesings. Die akuraatheid van ‘n gemiddelde arteriele bloeddruk ≥ 
125mmHg om ‘n sistoliese bloeddruk ≥ 160mmHg op te tel met gebruik van al die 
drie metodes is ook uitgewerk. 
 
RESULTATE: Daar was swak korrelasie tussen intra-arteriele sistoliese bloed druk 
(SBD) metings en outomatiese en manuele SBD (r = 0.34, p < 0.01; r = 0.41, p < 
0.01 onderskeidelik). Die gemiddelde verskille tussen outomatiese en manuele SBD 
wanneer vergelyk met intra-arteriele SBD was 24 ± 17mmHg (p < 0.01) en 20 ± 15 
mmHg (p < 0.01) onderskeidelik. Beter korrelasie was gevind tussen intra-arteriele 
diastoliese bloed druk (DBD) en outomatiese en manuele DBD (r = 0.61, p < 0.01; r = 
0.59, p < 0.01 onderskeidelik). Die gemiddelde verskille tussen outomatiese en 
manuele DBD wanneer dit vergelyk was met intra-arteriele DBD was nie statisties 
betekenisvol nie. Daar was swak korrelasie tussen intra arteriele gemiddelde 
arteriele bloeddruk en outomatiese gemiddelde arteriele bloeddruk (r = 0.44, p < 
0.01) en beter korrelasie met manuele gemiddelde arteriele bloeddruk (r = 0.56, p < 
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0.01). Die gemiddelde verskille van outomatiese en manuele gemiddelde arteriele 
bloeddruk was betekenisvol (5 ± 13mmHg, p < 0.01; 8 ± 11mmHg, p < 0.01 
onderskeidelik). Die sensitiwiteit van outomatiese en manuele metodes om ‘n intra-
arteriele SBD ≥ 160mmHg op te tel was 23.4% en 37.5% onderskeidelik. Die vermoë 
van ‘n gemiddelde arteriele bloeddruk ≥ 125mmHg om ‘n SBD ≥ 160mmHg op te tel, 
gemeet deur intra-arterieel, outomatiese en manuele metodes het lae sensitiwiteit 
getoon (35.9%, 21.9% en 17.2% onderskeidelik). 
 
GEVOLGTREKKING: Hierdie studie het gedemonstreer dat outomatiese en 
manuele metodes van bloeddruk meting nie akurate metodes is om ware intra-
arteriele sistoliese bloeddruk te meet in pasiente met erge pre-eklampsie tydens ‘n 
erge hipertensiewe episode nie. In hierdie omstandighede moet intra-arteriele 
bloeddruk gemeet word indien beskikbaar. Indien dit nie beskikbaar is nie moet die 
manuele aneroiede sfigmomanometer gebruik word. Onderskatting van bloeddruk, 
veral sistoliese bloeddruk, kan lei tot erge moederlike morbiditeit en mortaliteit. 
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Chapter 1 – Introduction and Literature 
Review  
 
 
One of the leading causes of maternal deaths in South Africa is directly related to 
hypertensive disease in pregnancy. In the Saving Mothers report 2002-2004, 628 of 
the 3406 maternal deaths were related to hypertensive disease in pregnancy. The 
commonest primary cause of hypertensive related deaths was eclampsia. The 
commonest final cause of death remains intracerebral haemorrhage.1, 2 
 
Pre-eclampsia is pregnancy specific and of a multisystemic nature where the 
complication rates are high. It is associated with both maternal and foetal 
complications. Maternal complications include intracerebral haemorrhage, pulmonary 
oedema, renal failure, HELLP (haemolysis, elevated liver enzymes, low platelets) 
syndrome, abruptio placentae, disseminated intravascular coagulopathy and liver 
haemorrhage. Foetal complications include severe intrauterine growth restriction, 
asphyxia, preterm birth and death.1, 3, 4 
 
In the past, one of the main focuses of pre-eclampsia was an elevated diastolic blood 
pressure (DBP) ≥ 110mmHg, and this was thought to be associated with an 
increased risk of intracerebral haemorrhage.5 Many earlier definitions of 
preeclampsia, including the classification by Davey and MacGillivray, did not even 
include systolic blood pressure (SBP) in their definition of hypertension.6 They felt 
that systolic blood pressure did not improve the diagnostic or prognostic significance 
of hypertension in pregnancy.7 As a result, the main focus of blood pressure 
management and treatment appeared to focus mainly on diastolic blood pressure.  
 
In more recent years, the emphasis has changed to focus on more adequate 
management of systolic blood pressure. The Seventh Report of the Confidential 
Enquiries into Maternal Deaths in the United Kingdom stated that intracranial 
haemorrhage was the single most common cause of death and this was often due to 
inadequate treatment of systolic hypertension.8 A study done by Martin et al showed 
that just preceding a stroke, 96% of patients had a SBP ≥ 160mmHg and only 12.5% 
had a DBP ≥ 110mmHg.9 
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It is thus crucial that hypertension in pregnancy is promptly and adequately 
managed.10 For blood pressure to be adequately managed, the accuracy of the 
methods used to measure blood pressure needs to be established. The standard 
method for measuring non-invasive blood pressure is sphygmomanometry and it is 
well recognised for its inaccuracy.11 Automated blood pressure machines are widely 
used in South Africa, despite the fact that they tend to underestimate blood 
pressure.1,2,10 Intra-arterial blood pressure monitoring is considered to be the gold 
standard for accurate blood pressure measurement.10,12 
 
Penny et al made a comparison between intra-arterial blood pressure and three 
methods of non-invasive blood pressure measurement: conventional 
sphygmomanometry and two automated blood pressure devices. In women with pre-
eclampsia, the automated devices significantly underestimated the systolic and the 
mean blood pressure. Conventional sphygmomanometry was found to underestimate 
the SBP and overestimate the DBP. Therefore the mean arterial pressure (MAP) was 
similar to that of the intra-arterial blood pressure.2 
 
A similar study was done by Natarajan et al using different automated blood pressure 
devices. Both automated devices consistently underestimated the systolic and 
diastolic blood pressure when compared with mercury sphygmomanometry and intra-
arterial measurements. Automated methods of blood pressure measurements were 
therefore not recommended for clinical use in patients with pre-eclampsia.10 
 
Pomini et al showed that there was a poor correlation between manual auscultatory 
and automated oscillometric methods for the measurement of blood pressure in 
normotensive pregnant women. It was concluded that even though an 
underestimation of only 10mmHg was shown, this could result in a delay in the 
correct diagnosis of pre-eclampsia.13 
 
A study done by Araghi12 and colleagues noted that in overweight critically ill patients 
with hypertension, non-invasive methods of blood pressure monitoring 
underestimated the blood pressure when compared to the gold standard of intra-
arterial blood pressure monitoring. They concluded that this might adversely affect 
therapeutic decisions and thereby have a negative effect on outcomes. 
 
Blood pressure measurement is still the most common screening test used in the 
antenatal care of patients.14 Patients may present with pre-eclampsia and acute 
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severe hypertension at any level of healthcare. Often the first point of presentation is 
at a primary healthcare facility, whereby invasive blood pressure monitoring is not 
available. Many healthcare facilities use either automated blood pressure monitoring 
devices or manual sphygmomanometry. It is therefore important to determine the 
more accurate method, especially when considering acute severe hypertension, 
where there is an increased risk of complications.1 
 
Inadequate and inappropriate management may be instituted if errors are made in 
diagnosing hypertension. However, blood pressure is a haemodynamic phenomenon 
and it is affected by numerous factors. Some of these factors include an inherent 
variability, limitations of the device as well as the accuracy of the device used.15 
 
Acute severe hypertension must be detected and treated. These patients deserve 
immediate and special attention in a high care or intensive care setting, where they 
can be administered antihypertensive treatment to reduce their risk of developing 
intracerebral haemorrhage.9 It is therefore of vital importance to correctly detect a 
SBP ≥ 160mmHg or a DBP ≥ 110mmHg to prevent a cerebral event. 
 
In the Obstetrics Critical Care Unit (OCCU) at Tygerberg Hospital, adequate 
infrastructure and trained personnel are often available, allowing for the use of intra-
arterial blood pressure monitoring when indicated. In the OCCU, the indications for 
intra-arterial blood pressure monitoring include acute severe hypertension not 
controlled with routine management requiring intravenous antihypertensive 
treatment, severe preeclampsia with organ dysfunction, recurrent eclampsia and 
hypertensive encephalopathy. However, in the labour ward at Tygerberg hospital, 
there are no routine facilities available for intra-arterial blood pressure monitoring. 
Therefore, the blood pressures of patients with severe pre-eclampsia in the labour 
ward are routinely measured, mostly using automated blood pressure devices and 
aneroid sphygmomanometers. If this method of obtaining blood pressure is 
remarkably inaccurate, it could result in undetected episodes of acute severe 
hypertension, resulting in an increased incidence of cerebral complications, 
intracerebral haemorrhage and death. 
 
Severe pre-eclampsia is common in obstetric practice, and it is unclear as to whether 
invasive and non-invasive blood pressure monitoring may be used interchangeably. 
There are very few studies comparing intra-arterial blood pressure measurements 
with conventional sphygmomanometry and automated blood pressure devices. There 
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are even fewer studies comparing this in patients with pre-eclampsia. No studies 
were identified in this literature review, comparing invasive and non-invasive blood 
pressure monitoring in patients with severe pre-eclampsia, during a hypertensive 
blood pressure peak (i.e. SBP ≥ 160mmHg or DBP ≥ 110mmHg). However, gaining 
enough evidence with regards to this comparison is crucial to allow for adequate 
control of very high blood pressures, thus preventing both maternal and foetal 
morbidity and mortality. 
 
The aim of this descriptive cross sectional study is to test the hypothesis that non-
invasive blood pressure monitoring, especially when using automated devices, is not 
an accurate measure of blood pressure and often underestimates a true blood 
pressure reading when compared to intra-arterial blood pressure monitoring in pre-
eclamptic patients with acute severe hypertension. 
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Chapter 2 - Methods 
 
The study was conducted in the Obstetrics Critical Care Unit (OCCU) at Tygerberg 
Hospital. The University of Stellenbosch Research Ethics Committee approved the 
study protocol. The approval reference number was N08/10/308. 
 
The sample size for blood pressure readings during hypertensive crises was 
calculated using the power of 80 with a confidence level of 95%. A normal distribution 
of the continuous variable was assumed for the calculation. A mean difference of 
10mmHg was used and a standard deviation was calculated comparing intra-arterial 
systolic blood pressure with oscillometric automated systolic blood pressure.16 This 
calculation determined a sample size of 70 blood pressure readings in each group.  
 
Patients admitted to the OCCU, who had acute severe hypertension and confirmed 
pre-eclampsia, where intra-arterial blood pressure monitoring was indicated, were 
asked to participate in the study. Written informed consent was obtained from all 
patients who agreed to participate, prior to being entered into the study. A copy of the 
consent form is attached (appendix A).Participating in the study did not compromise 
patient care or management in any way. Patients who fulfilled the above-mentioned 
inclusion criteria were consecutively recruited by the doctors working in the OCCU. 
 
Pre-eclampsia was defined as the onset of hypertension with ≥ 2+ persistent 
proteinuria after twenty weeks gestation.6,17 Acute severe hypertension was defined 
as either a systolic blood pressure (SBP) of ≥160mmHg or a diastolic blood pressure 
(DBP) of ≥110mmHg.9,18 A total of 23 patients were recruited over a period of six 
months, from August 2009 to January 2010. 
 
Patients admitted to the OCCU who did not have severe pre-eclampsia, or those with 
pre-eclampsia who did not require an intra-arterial line for blood pressure monitoring, 
were excluded from the study. No patient received an intra-arterial line purely for the 
purposes of the study. Patients with severe pre-eclampsia, who were not admitted to 
the OCCU, were also excluded from the study.  
 
The doctors in the OCCU performed the intra-arterial catheterisation. A 20 gauge 
radial artery set (BD critical care arterial cannula with flow switch) was used for 
continuous intra-arterial blood pressure monitoring. Before each data collection, a 
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rapid flush test was performed to test for the adequacy of the pressure monitoring 
system. The arterial waveform was observed and recorded from the monitor (Nihon 
Kohden BSM – 4113K). The automated oscillometric non-invasive blood pressure 
monitoring was also done using the Nihon Kohden BSM – 4113K monitor. The 
manual blood pressure was taken using the Welch Allyn Maxi Stabil 3 aneroid 
sphygmomanometer, which was A grade and validated to the British Hypertension 
Society protocol, as stated on the apparatus. All equipment is calibrated and serviced 
on a regular basis. 
 
Each time the patient had a hypertensive blood pressure peak, i.e. either a SBP ≥ 
160mmHg or a DBP ≥ 110mmHg on the invasive intra-arterial blood pressure 
monitor, an oscillometric automated blood pressure and a blinded manual blood 
pressure using the aneroid sphygmomanometer was immediately documented, 
followed by prompt treatment of the hypertensive peak. This was performed for a 
maximum of five hypertensive blood pressure peaks per patient. From this point, the 
automated oscillometric blood pressure will be referred to as the automated blood 
pressure, and the manual aneroid sphygmomanometer blood pressure will be 
referred to as the manual blood pressure. 
 
The manual blood pressure was a blinded reading obtained by either nursing staff or 
medical doctors. The blood pressure monitor was covered with a screen, so that the 
nursing staff or medical doctor measuring and recording the manual blood pressure 
would remain unaware of the actual intra-arterial or automated blood pressure 
measurements. 
 
Manual blood pressures were measured using the left arm with the patient semi-
recumbent in the left lateral position. The left arm was at the level of the heart, as 
recommended by the Australasian Society for the Study of Hypertension in 
Pregnancy (ASSHP).17 The height, weight and the arm circumference at mid-arm 
level were documented for each patient to ensure selection of the correct cuff size.19 
When measuring the manual blood pressure using aneroid sphygmomanometry, 
Korotkoff phase V was documented as the diastolic blood pressure.20, 21 
 
All demographic information and blood pressure measurements were documented on 
a data sheet (Appendix B and C). 
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Objectives: 
The primary outcome of this study was to determine the accuracy of the automated 
and manual SBP when compared to the intra-arterial SBP.  
 
The secondary outcomes were as follow: 
1. To determine the accuracy of automated and manual DBP, when compared 
to the intra-arterial DBP 
2. To determine the accuracy of the MAP of the automated and manual blood 
pressures, when compared to the intra-arterial MAP 
3. To determine whether there is a correlation between the MAP ≥ 125mmHg, 
using the three different methods of SBP measurement, and that of acute 
severe systolic hypertension i.e. SBP ≥ 160mmHg. 
 
 
Statistical methods: 
All summary values are expressed as the mean ± standard deviation, unless 
otherwise stated. Correlation was determined using the Pearson correlation 
coefficient. For continuous variables, a paired Student’s t test was used to compare 
the mean differences between intra-arterial, automated and manual blood pressure 
measurements. A two-tailed P value of less than 0.05 was considered statistically 
significant. For categorical variables, clinically important cut-off points were used and 
data analysed using Chi-square tests. A P value of less than 0.05 was considered 
statistically significant. Statistical analysis was performed using STATA version 10. 
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Chapter 3 - Results 
 
A total of 71 blood pressure readings for each method were collected over a period of 
six months. However, only 66 blood pressure readings were analysed. Five blood 
pressure readings could not be analysed due to incomplete or incorrectly 
documented data on the data collection sheet. 
 
Twenty-three patients with the mean age of 27 years (range 16 – 40 years) with a 
mean gestational age of 32 weeks (range 22 – 40 weeks) were included in the study. 
All patients were currently being treated with antihypertensive medication. All patients 
had ≥ 2+ persistent proteinuria on the urine dipstick. Patient characteristics are 
summarised below [Tables 1 and 2]. 
 
 
             Table 1. Patient characteristics with means and ranges 
 Mean/Median Range 
Age (yrs) 27 16 - 40 
Gravidity (Median) 2 1 - 6 
Parity (Median) 2 0 - 6 
Gestation (wks) 32 22 - 40 
Arm circumference (cm) 28 22 - 37 
Weight (Kg) 72 45 - 110 
Length (cm) 156 144 - 182 
Body Mass Index  (Kg/m²) 29.5 19.5 – 45.8 
Systolic blood pressure (mmHg)* 166 139 - 220 
Diastolic blood pressure (mmHg)* 111 90 - 150 
            *Reflects systolic and diastolic blood pressure at point of entry into the study 
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            Table 2. Patient characteristics expressed as a percentage 
 Patients (n) Percentage (%) 
Primigravida 7 30.4 
Multigravida 16 69.6 
New paternity 17 73.9 
Antepartum 5 21.7 
Postpartum 18 78.3 
Previous pre-eclampsia 4 25 
Chronic hypertension 1 4.3 
HIV positive* 3 13 
Smokers 4 17.4 
Any alcohol consumption 3 13 
Protein (≥ 2+) 23 100 
            * HIV, Human immunodeficiency virus. 
 
The complications of pre-eclampsia encountered by the patients in the study are 
summarised below [Table 3].  
 
            Table 3. Preeclampsia complications 
 Patients (n) 
Percentage 
(%) 
Pulmonary oedema* 8 34.8 
HELLP syndrome† 7 30.4 
Eclampsia 5 21.7 
Renal dysfunction‡ 5 21.7 
Abruptio placentae 1 4.3 
Intracerebral haemorrhage 1 4.3 
Hypertensive encephalopathy 1 4.3 
Subcapsular liver haematoma 1 4.3 
           * Diagnosed clinically and radiologically 
           † HELLP, haemolysis, elevated liver enzymes and low platelets
9
 
           ‡ Oliguria < 100mls/4hrs; oliguria ≤ 400mls/24hrs; increase in creatinine by  
               44mmol/l/day; acute deterioration in urea ≥ 15mmol/l or of creatinine to ≥   
               400mmol/l/day
22
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THE CORRELATION BETWEEN INTRA-ARTERIAL BLOOD PRESSURE 
MEASUREMENTS AND AUTOMATED AND MANUAL METHODS OF 
BLOOD PRESSURE MEASUREMENT 
 
 
There was poor correlation between intra-arterial SBP measurements and automated 
SBP measurements. The correlation coefficient (r) = 0.34 (p < 0.01). The mean intra-
arterial SBP was 172 ± 11mmHg, whereas the mean automated SBP was 148 ± 
18mmHg, giving a mean difference of 24 ± 17mmHg (p < 0.01). The scatter plot in 
Figure 1 shows that the automated instrument consistently underestimated intra-
arterial systolic blood pressures.  
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Figure 1. Scatter plot comparing intra-arterial SBP measurements with automated SBP 
measurements (x-axis = automated SBP; y-axis = intra-arterial SBP) 
 
 
There was poor correlation when comparing intra-arterial SBP measurements with 
manual SBP measurements [r = 0.41 (p < 0.01)]. The mean manual SBP was 152 ± 
15 mmHg with a mean difference of 20 ± 15 mmHg (p < 0.01). The scatter plot in 
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Figure 2 shows that the manual instrument also consistently underestimated intra-
arterial systolic blood pressures. 
 
1
4
0
1
6
0
1
8
0
2
0
0
100 120 140 160 180 200
Systolicm
Systolica Fitted values
 
Figure 2. Scatter plot comparing intra-arterial SBP measurements with manual SBP 
measurements (x-axis = manual SBP; y-axis = intra-arterial SBP) 
 
 
There was better correlation between intra-arterial DBP measurements and 
automated DBP measurements [r = 0.61 (p < 0.01)]. The mean intra-arterial DBP 
was 94 ± 11mmHg. The mean automated DBP was 96 ± 12mmHg with a mean 
difference of 2 ± 10mmHg. This was not statistically significant (p = 0.20). The scatter 
plot in Figure 3 shows that the automated instrument often overestimated intra-
arterial diastolic blood pressures. 
 
There was also better correlation between intra-arterial DBP measurements and 
manual DBP measurements [r = 0.59 (p < 0.01)]. The mean manual DBP was 94 ± 
14mmHg with a mean difference of 1 ± 12mmHg. This was not statistically significant 
(p = 0.65). The scatter plot in Figure 4 shows that the manual instrument both equally 
overestimated and underestimated the intra-arterial diastolic blood pressure. 
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Figure 3. Scatter plot comparing intra-arterial DBP measurements with automated DBP 
measurements (x-axis = automated DBP; y-axis = intra-arterial DBP) 
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Figure 4. Scatter plot comparing intra-arterial DBP measurements with manual DBP 
measurements (x-axis = manual DBP; y-axis = intra-arterial DBP) 
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There was poor correlation when comparing the MAP of intra-arterial blood pressure 
with the MAP of the automated blood pressure [r = 0.44 (p < 0.01)]. The mean MAP 
for intra-arterial blood pressure was 121 ± 11mmHg. The mean MAP for the 
automated blood pressure was 116 ± 13mmHg with a mean MAP difference of 5 ± 
13mmHg (p < 0.01). The scatter plot in Figure 5 shows that the automated device 
consistently underestimated the intra-arterial MAP. 
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Figure 5. Scatter plot comparing intra-arterial MAP measurements with automated MAP 
measurements (x-axis = automated MAP; y-axis = intra-arterial MAP) 
 
There was good correlation between the MAP of intra-arterial blood pressure and the 
MAP of the manual blood pressures [r = 0.56 (p < 0.01)]. The mean MAP for the 
manual blood pressure was 113 ± 13mmHg and a mean MAP difference of 8 ± 
11mmHg (p < 0.01) was noted. The scatter plot in Figure 6 shows that the manual 
device also consistently underestimated the intra-arterial MAP. 
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Figure 6. Scatter plot comparing intra-arterial MAP measurements with manual MAP 
measurements (x-axis = manual MAP; y-axis = intra-arterial MAP) 
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CATEGORICAL DATA DETERMINING THE ACCURACY OF VARIOUS 
BLOOD PRESSURE METHODS IN DETECTING ACUTE SEVERE 
HYPERTENSION 
 
A SBP ≥ 160mmHg was used as a marker for severe systolic hypertension as the 
National Enquiries into Maternal Death from the United Kingdom currently 
recommend treatment for SBP ≥ 160mmHg in order to prevent intracranial 
haemorrhage.8 
 
A MAP ≥ 125mmHg was used as a marker of severe hypertension, as Sibai et al 
recommended the commencement of antihypertensive treatment in patients with 
severe pre-eclampsia when the MAP ≥ 125mmHg.23 
 
The accuracy of other methods of SBP measurements i.e. automated oscillometric 
and manual aneroid sphygmomanometer in detecting an intra-arterial SBP ≥ 
160mmHg showed poor sensitivity [Table 4]. 
 
 
Table 4. Accuracy of other methods in detecting an intra-arterial SBP ≥ 160mmHg  
 
Sensitivity  
(95% CI) 
Specificity  
(95% CI) 
Positive 
predictive 
value  
(95% CI) 
Negative 
predictive 
value  
(95% CI) 
Automated 
23.4 % 
 (14.75-35.13) 
100 % 
(34.24–100) 
100 % 
(79.61–100) 
3.9 % 
 (1.08–13.22) 
Manual 
37.5 % 
(26.67-49.75) 
50 % 
(9.45-90.55) 
96 % 
(80.46-99.29) 
2.4 % 
(0.43-12.6) 
Automated, oscillometric blood pressure; Manual, aneroid sphygmomanometer  
CI, confidence level 
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The accuracy of other methods of MAP measurements in detecting an intra-arterial 
MAP ≥ 125mmHg also demonstrated poor sensitivity but good specificity [Table 5]. 
 
Table 5. Accuracy of other methods in detecting an intra-arterial MAP ≥ 125mmHg 
 
Sensitivity  
(95% CI) 
Specificity 
(95% CI)  
Positive 
predictive 
value  
(95% CI) 
Negative 
predictive 
value 
(95% CI) 
Automated 
44 % 
(26.67-62.93) 
90.2 % 
(77.45-96.14) 
73.3 % 
(48.05-89.1) 
72.6 % 
(59.05-82.89) 
Manual 
36 % 
(20.25-55.48) 
92.7 % 
(80.57-97.48) 
75 % 
(46.77-91.11) 
70.4 % 
(57.17-80.86) 
Automated, oscillometric blood pressure; Manual, aneroid sphygmomanometer 
CI, confidence level 
 
The accuracy of the MAP ≥ 125mmHg in detecting episodes of acute severe systolic 
hypertension i.e. SBP ≥ 160mmHg demonstrated poor sensitivity and specificity 
[Table 6]. 
 
Table 6. Accuracy of MAP ≥ 125mmHg, using 3 methods, in detecting intra-arterial SBP ≥ 
160mmHg 
 
Sensitivity 
 (95% CI) 
Specificity 
(95% CI) 
Positive 
predictive 
value 
(95% CI) 
Negative 
predictive 
value  
(95% CI) 
A-line 35.9 % 
(25.29-48.18) 
0 % 
(0.0-65.76) 
92 % 
(75.03-97.78) 
0 % 
(0.0-8.57) 
Automated 
21.9 % 
(13.5-33.43) 
50 % 
(9.46-90.55) 
93.3 % 
(70.18-98.81) 
2 % 
(0.35-10.3) 
Manual 
17.2 % 
(9.88-28.21) 
50 % 
(9.45-90.55) 
91.7 % 
(64.61-98.51) 
1.9 % 
(0.33-9.77) 
A-line, intra-arterial line; Automated, oscillometric blood pressure; Manual, aneroid 
sphygmomanometer 
CI, confidence level  
 
 
 
 
 
 
 28 
Chapter 4 - Discussion 
 
In this study, both the automated and manual blood pressure devices significantly 
underestimated systolic blood pressure during an acute hypertensive blood pressure 
peak. The automated and manual methods of SBP measurements were not very 
accurate in detecting episodes of a SBP ≥ 160mmHg. There was poor correlation 
between the automated and manual SBP measurements when compared to intra-
arterial SBP measurements [r = 0.34 (p < 0.01); r = 0.41 (p < 0.01) respectively]. The 
automated SBP only agreed one third of the time when compared to the intra-arterial 
SBP. The manual SBP only agreed two fifths of the time when compared to the intra-
arterial SBP. When comparing the mean automated and the mean manual SBP to 
that of the mean intra-arterial SBP, a statistically significant mean difference was 
found for each. The mean difference of the manual SBP was smaller than that of the 
automated SBP measurements (20 ± 15mmHg vs. 24 ± 17mmHg respectively). 
These findings were similar to that of a study done by Penny et al2, where the mean 
difference of automated SBP was 15 – 18mmHg and conventional 
sphygmomanometry underestimated SBP by 7mmHg. In the study done by 
Natarajan et al, the automated oscillometric device significantly underestimated the 
mean SBP by 19mmHg when compared to the mean intra-arterial SBP.10 In our 
study, the automated SBP underestimated the intra-arterial SBP by up to 52mmHg. 
Even though the manual SBP underestimated the intra-arterial SBP by up to 
68mmHg, the mean difference was 20 ± 15mmHg, making this manual method of 
blood pressure measurement more accurate than automated methods when 
measuring systolic blood pressure. Both methods of SBP measurement will result in 
numerous undetected systolic events, resulting in inadequate intervention and 
possible intracerebral haemorrhage. 
 
There was no significant difference found when comparing the mean automated and 
mean manual DBP to that of the mean intra-arterial DBP. The mean difference was 
small (-2 ± 10mmHg, p = 0.20 and 1±12mmHg, p= 0.65 respectively). The automated 
DBP and the manual DBP overestimated the true intra-arterial DBP measurements 
56% and 48.5% of the time, respectively. The automated DBP overestimated by up 
to 24mmHg while the manual DBP measurements were overestimated by up to 
25mmHg. In the study by Natarajan et al, there was also no significant finding when 
comparing the mean automated oscillometric DBP to that of the mean intra-arterial 
DBP measurements, and they were found to be similar.10 In the study by Penny et al, 
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the mean automated DBP was underestimated by 11mmHg but the mean manual 
DBP also overestimated by 6mmHg.2 However, systolic hypertension has become 
more important over recent years, owing to its close association with intracerebral 
complications.9 
 
When recruiting patients for the study, either a SBP ≥ 160mmHg or a DBP ≥ 
110mmHg was required, not both. Only 2 of 66 (3%) of the intra-arterial SBP 
readings were < 160mmHg, indicating that systolic hypertension in our study group 
was far more common than diastolic hypertension when detecting acute severe 
hypertension. However, only 7 of 66 (10.6%) of the intra-arterial DBP readings were 
≥ 110mmHg. This could account for the small mean difference and lack of statistical 
significance when analysing methods of DBP measurements. Therefore, a greater 
sample size analysing DBP ≥ 110mmHg is most likely needed, and this difference 
may change if more patients with DBP ≥ 110mmHg only, are analysed. 
 
The automated MAP only correlated with the intra-arterial MAP two fifths of the time, 
while the manual MAP correlated almost two thirds of the time. These findings were 
statistically significant [r = 0.44 (p < 0.01); r = 0.56 (p < 0.01)] respectively. The mean 
difference of the MAP of the automated blood pressure was smaller than the mean 
difference of the MAP of the manual blood pressure when compared to the mean 
difference of the intra-arterial MAP (5 ± 13mmHg and 8 ± 11mmHg respectively), 
both statistically significant. This is most likely explained by the fact that the 
automated DBP often overestimated the true intra-arterial DBP, resulting in the 
automated MAP value being closer to the intra-arterial MAP, than that of the manual 
MAP. In the studies by Penny et al and Natarajan et al, the automated devices 
underestimated MAP, which corresponded to the findings in this study.2, 10 
 
The automated and manual methods of SBP measurements were not very accurate 
in detecting episodes of a SBP ≥ 160mmHg. Neither were the automated and manual 
methods of MAP measurement very accurate in detecting a MAP ≥ 125mmHg. The 
sensitivities of all methods were low, ranging from 23.4% to 44%. This implies that a 
SBP ≥ 160mmHg will not be detected in up to 62% of cases when using automated 
or manual methods of SBP measurements. A MAP ≥ 125mmHg will not be detected 
in more than 56% of the cases when using automated or manual methods of 
determining the MAP. The MAP may not always predict a high systolic blood 
pressure, especially with large pulse pressures.8 
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 In this study, we used the cut-off point for MAP as ≥ 125mmHg in detecting a SBP ≥ 
160mmHg, as the findings in the study by Martin et al show that the majority of 
patients did not have a MAP ≥ 130mmHg (20.8% of patients) but almost half had a 
MAP ≥ 125mmHg (45.8% of patients) just prior to having a stroke.9 Sibai et al also 
considered a MAP ≥ 125mmHg an indication for the commencement of 
antihypertensive treatment in patients with severe pre-eclampsia.23 In this study, a 
MAP ≥ 125mmHg was also not very accurate in detecting a systolic blood pressure ≥ 
160mmHg, when using all three methods of blood pressure measurements. There 
was a low sensitivity and specificity for all three methods thereby confirming the 
findings of Martin et al.9 This may have serious implications as many episodes of 
severe hypertension will not be detected and will therefore be left untreated, resulting 
in an increased incidence of serious maternal morbidity and even mortality, 
especially that of intracerebral haemorrhage. Even though the specificity was high 
most of the time, a high sensitivity would be far better appreciated, as it is more 
important to accurately detect severe hypertension as opposed to excluding it.  
 
When comparing the complications rates of severe preeclampsia observed in our 
study with those observed in another study in Pretoria, South Africa, they varied 
somewhat.22 These differences may be due to differences in the population group 
studied, different management protocols and differences in hospital facilities and 
infrastructure. Pulmonary oedema was our most common complication (34.8%) 
encountered which was only found to be 26% in Pretoria. Our second most common 
complication was that of HELLP syndrome (30.4%), which was similar to that in 
Pretoria. Eclampsia and renal complications were the third and fourth most common 
complications in our study with an equal complication rate of 21.7% each. One 
patient in our study had the unfortunate complication of intracerebral haemorrhage. 
While the study was in progress, there was another patient who had been intubated 
and ventilated due to an intracerebral haemorrhage, and at least one other with 
hypertensive encephalopathy. They were not included in the study as the ability to 
obtain consent for inclusion into the study was not possible. This would have raised 
the rate of cerebral complications as high as 16%. This finding would be similar to the 
14.4% of cerebral complications found in the study done in Pretoria.22 
 
In our methods, Korotkoff phase V was used when measuring the manual blood 
pressure as this has been shown to be more accurate than Korotkoff phase IV when 
documenting diastolic blood pressure during pregnancy. However, in some pregnant 
women, Korotkoff V is heard until the blood pressure is zero. Under these 
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circumstances, the use of Korotkoff IV to determine the diastolic blood pressure is 
acceptable.20, 21 Considering the fact that the majority of patients were reasonably ill, 
only five blood pressure readings were taken per patient for the sake of patient 
comfort. 
 
As our search found no literature regarding a study of this nature, the assumption of 
a mean difference of 10mmHg was made after consultation with critical care 
consultants in the unit, along with observations of differences in blood pressure 
measurements when using different methods. The American Association for Medical 
Instrumentation states that when comparing indirect blood pressure measurements 
with direct blood pressure measurements, there needs to be a difference of less than 
5mmHg, for an indirect reading to be considered accurate.24 However, we assumed 
that a difference of 5mmHg may be too small for any clinical significance, and since 
our search found no study comparing the differences between the methods of blood 
pressure measurement at the time of a hypertensive blood pressure peak, a mean 
difference of 10mmHg was used. 
 
One of the main strengths of this study was that it focussed on systolic hypertension 
during an acute hypertensive blood pressure peak. There were few or no studies that 
have looked at the accuracy of blood pressure measurements during a hypertensive 
peak. This is clinically relevant, as accurately determining the correct blood pressure 
will result in appropriate and timely intervention with antihypertensive treatment, 
thereby decreasing maternal morbidity and mortality. As the OCCU is a four bed unit, 
the study was conducted in a controlled environment, thus allowing for stringent 
quality control in methods of blood pressure measurement. 
 
One of the weaknesses of this study was possible observer bias, which may have 
influenced the manual blood pressure measurements. Even though the nursing 
personnel or the doctor measuring the manual blood pressure was blinded to the 
intra-arterial and automated blood pressure readings, they may have known that the 
patient had acute severe hypertension. This could have resulted in the 
documentation of a manual blood pressure reading that is higher than the actual 
manual blood pressure measurement. Despite taking the above into consideration, 
the systolic manual blood pressure still underestimated the intra-arterial systolic 
blood pressure. Unfortunately, there were few patients with diastolic hypertension, 
and this may have influenced our findings when comparing the methods of diastolic 
blood pressure measurements. 
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The Nihon Kohden BSM – 4113K monitor used in this study measures automated 
oscillometric blood pressure and has not been validated for use in pre-eclamptic 
women. Neither has the Welch Allyn Maxi Stabil 3 aneroid sphygmomanometer been 
validated for this purpose. There are very few monitors that have been validated for 
use in women with pre-eclampsia. This may have influenced our findings with both 
manual and automated blood pressure measurements. However, automated 
oscillometric methods of blood pressure measurement are considered more reliable 
than automated auscultatory methods of blood pressure measurement.11 This was 
also shown in the study by Natarajan et al whereby the automated auscultatory 
monitor consistently underestimated more blood pressure measurements than the 
automated oscillometric monitor when compared to mercury sphygmomanometry.10 
 
Intra-arterial blood pressure monitoring still appears to be the gold standard when 
managing complicated pre-eclamptic patients with acute severe hypertension. 
Unfortunately, it is not possible to manage every patient with acute severe 
hypertension invasively, as an ongoing shortage of equipment and staff will be a 
limiting factor in our labour ward. Manual aneroid sphygmomanometry is still more 
accurate than automated oscillometric methods of blood pressure measurements. 
However, in a busy labour ward where a shortage of staff is still a reality, an 
automated method of blood pressure measurement would me more convenient but 
possibly detrimental. However, it is of outmost importance to be aware of the 
consequences of an undetected hypertensive blood pressure peak as the under 
treatment of blood pressure in patients with acute severe hypertension may lead to 
severe and possibly preventable maternal morbidity and mortality.  
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Conclusion 
 
In conclusion, both the automated and manual methods of blood pressure 
measurements were not an accurate measure of the true intra-arterial blood 
pressure, when managing pre-eclamptic patients with acute severe hypertension. In 
such situations, intra-arterial blood pressure monitoring should be used when 
possible. When this is not possible, manual aneroid sphygmomanometry is 
recommended, as this is still more accurate than automated oscillometric methods of 
blood pressure measurement. Underestimating blood pressure, particularly SBP, 
may lead to severe maternal morbidity and mortality.  
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Addendum A 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
 
 
TITLE OF THE RESEARCH PROJECT: 
 
The accuracy of non-invasive blood pressure monitoring when compared to 
intra-arterial blood pressure monitoring in patients with severe pre-eclampsia 
during an acute hypertensive crisis 
 
 
REFERENCE NUMBER: N08/10/308 
 
PRINCIPAL INVESTIGATOR: Dr S Dalla 
 
ADDRESS: Obstetrics High Care Unit 
                    Tygerberg Hospital 
                    Tygerberg 
                     7505 
 
CONTACT NUMBER: 021 938 5968 
 
You are being invited to take part in a research project.  Please take some 
time to read the information presented here, which will explain the details of 
this project.  Please ask the study staff or doctor any questions about any part 
of this project that you do not fully understand.  It is very important that you 
are fully satisfied that you clearly understand what this research entails and 
how you could be involved.  Also, your participation is entirely voluntary and 
you are free to decline to participate.  If you say no, this will not affect you 
negatively in any way whatsoever.  You are also free to withdraw from the 
study at any point, even if you do agree to take part. 
 
This study has been approved by the Committee for Human Research at 
Stellenbosch University and will be conducted according to the ethical 
guidelines and principles of the international Declaration of Helsinki, South 
African Guidelines for Good Clinical Practice and the Medical Research 
Council (MRC) Ethical Guidelines for Research. 
 
What is this research study all about? 
The study will take place in the Obstetrics High Care Unit at Tygerberg 
Hospital. Initially, at least 20 patients will be recruited. If necessary, more 
patients will be invited to participate in the study. 
 
The project aims to measure and compare three different ways in which we 
can measure the blood pressure in patients with severe pre-eclampsia. Pre-
eclampsia is when the blood pressure is raised and there is protein in the 
urine. When pre-eclampsia is severe, the blood pressure is very high. This is 
very dangerous for both the pregnant mother and her baby. For the mother, 
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pre-eclampsia may result in the placenta separating from the uterus causing 
excessive bleeding, water on the lungs, kidney failure, bleeding and clotting 
problems, seizures, stroke and may even result in death. Complications for 
the baby include growth restriction, preterm birth and death.  By doing this 
study, we will be able to determine which method is the most accurate for 
measuring the blood pressure. This will allow for us to better manage blood 
pressure, thereby preventing the above-mentioned complications. 
 
If you have severe pre-eclampsia and are admitted to the Obstetric High Care 
Unit, we routinely measure the blood pressure with an intra-arterial line and 
an automated blood pressure device. An intra-arterial line is a plastic cannula, 
which is inserted into an artery in the arm. It is then connected via a thin 
plastic line to a monitor, so that we can directly measure the blood pressure. 
An automated blood pressure device has a blood pressure cuff attached to a 
small monitor. The blood pressure cuff is wrapped around the upper arm and 
the monitor will then automatically read your blood pressure. You may be 
familiar with this device, as it is often used at local clinics and pharmacies for 
measuring the blood pressure. This usually forms part of your routine 
management for blood pressure monitoring if you are admitted to the 
Obstetrics High Care Unit, whether or not you choose to participate in the 
study. 
 
If you choose to participate in the study, a third method for monitoring the 
blood pressure will be done. This will be done each time the blood pressure is 
very high. Manual sphygmomanometry will be used. This means that a nurse 
or doctor will manually wrap a blood pressure cuff around your arm and 
personally listen to your blood pressure. This will be the only thing that is done 
in addition to your routine management whilst in the Obstetric High Care Unit. 
 
All the blood pressure readings from all three methods from all the patients 
involved in the study will then be compared, and the most accurate method for 
measuring blood pressure will be determined. 
 
No medication will be used for this study. 
 
 
Why have you been invited to participate? 
You have severe pre-eclampsia. As mentioned earlier, this is when the blood 
pressure is very high and is accompanied by protein in the urine. 
You have been admitted to the Obstetric High Care Unit. 
You already have, or require an intra-arterial line for blood pressure 
monitoring. 
 
These are all the criteria that need to be fulfilled prior to being invited to 
participate in the study. You have been invited to participate in the study as 
you meet all the above-mentioned criteria that are required for inclusion into 
the study. 
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What will your responsibilities be? 
There are no responsibilities that need to be fulfilled from your side. 
 
 
Will you benefit from taking part in this research? 
If the most accurate methods of measuring blood pressure can be established 
and used, it will largely improve management and reduce the complications of 
patients with severe pre-eclampsia. This will play an important role in 
decreasing the complications of stroke and death in young women. This will 
be of great benefit to future patients that are diagnosed with severe pre-
eclampsia. 
 
 
Are there any risks involved in your taking part in this research? 
There are no risks involved in you participating in this study. 
 
 
If you do not agree to take part, what alternatives do you have? 
You are not obliged to participate in the study and your participation is 
completely voluntary. If you choose not to be a participant in the study, your 
treatment for severe pre-eclampsia will not be affected in any way. Your blood 
pressure will still be routinely monitored using an intra-arterial line as well as 
an automated blood pressure device. The only difference would be that we 
would no longer do a manual blood pressure reading each time you have a 
very high blood pressure peak. 
 
 
Who will have access to your medical records? 
All the information that we obtain from you, or your medical folder, will be kept 
strictly confidential. You will be allocated a number or a code, so your name 
will never be used. In this way, your identity will always be protected. In the 
event of your information being used in a publication or thesis, all information 
will be reported with anonymity. Only the principal investigator and the co-
investigator will have access to your medical records. 
 
 
What will happen in the unlikely event of some form injury occurring as 
a direct result of your taking part in this research study? 
As the study only involves taking a manual blood pressure measurement in 
addition to your routine management in the Obstetrics High Care Unit, an 
injury occurring as a direct result of your participating in this research study is 
not likely. 
 
 
 40 
Will you be paid to take part in this study and are there any costs 
involved? 
 
You will not be paid to participate in the study, but your transport and meal 
costs will be covered if a study visit is necessary.  There will be no financial 
costs involved for you if you do participate. 
 
 
Is there any thing else that you should know or do? 
You can contact Dr S Dalla at tel. 021-938 5968 if you have any further 
queries or encounter any problems. 
You can contact the Committee for Human Research at 021-938 9207 if you 
have any concerns or complaints that have not been adequately addressed 
by your study doctor. 
You will receive a copy of this information and consent form for your own 
records. 
 
 
Declaration by participant 
 
By signing below, I …………………………………..…………. agree to take part 
in a research study entitled , The accuracy of non-invasive blood pressure 
monitoring when compared to intra-arterial blood pressure monitoring 
in patients with severe pre-eclampsia during an acute hypertensive 
crisis . 
 
I declare that: 
 
 I have read or had read to me this information and consent form 
and it is written in a language with which I am fluent and 
comfortable. 
 I have had a chance to ask questions and all my questions have 
been adequately answered. 
 I understand that taking part in this study is voluntary and I have 
not been pressurised to take part. 
 I may choose to leave the study at any time and will not be 
penalised or prejudiced in any way. 
 I may be asked to leave the study before it has finished, if the study 
doctor or researcher feels it is in my best interests, or if I do not 
follow the study plan, as agreed to. 
 
 
Signed at (place) ....................................... on (date)…………....……….. 2009. 
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 ...............................................................  ............................................................  
Signature of participant Signature of witness 
 
 
Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 
 I explained the information in this document to 
………………………………….. 
 I encouraged him/her to ask questions and took adequate time to 
answer them. 
 I am satisfied that he/she adequately understands all aspects of the 
research, as discussed above 
 I did/did not use an interpreter.  (If an interpreter is used then the 
interpreter must sign the declaration below. 
 
 
Signed at (place) ......................…........……on (date) ...…………………. 2009. 
 
 
 
 
 ...............................................................  ............................................................  
Signature of investigator Signature of witness 
 
 
Declaration by interpreter 
 
I (name) ……………………………………………..……… declare that: 
 
 I assisted the investigator (name) 
………………………………………. to explain the information in this 
document to (name of participant) 
……………..…………………………….. using the language medium 
of Afrikaans/Xhosa. 
 We encouraged him/her to ask questions and took adequate time 
to answer them. 
 I conveyed a factually correct version of what was related to me. 
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 I am satisfied that the participant fully understands the content of 
this informed consent document and has had all his/her question 
satisfactorily answered. 
 
 
Signed at (place)............…........…………….. on (date)………....……….. 2009. 
 
 
 
 ...............................................................  ............................................................  
Signature of interpreter Signature of witness 
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Name:
Folder no.:
Area:………………….
Age:…………………..
Gravidity:…………… Parity:….
Race:…………………
Gestation:…………… Upper arm circum……………..cm
Postpartum:………… yes no
Weight:…………kg Length: …………… BMI:……..
BP:…………………. Protein: ……………
New paternity:….. yes no
Previous PET:…….. yes no
CHPT:……………….. yes no
RVD:………………. yes no CD4:…….
PMhx:………………. ………….. ………….…………… ………….. ………….. …………..……………..
Complications:……. hellp p oedema renal eclampsia
other …………………………………………..
Smoker:……………. yes no Quantity: ………….
Alcohol:……………. yes no Quantity: ………….
MgSO4:…………….. yes no
AntiHPT's 
used:…………………
……………………….. labetolol adalat nepresol tridil
adalat xl aldomet other…………………….
AntiHPT's before 
pregnancy:………….
……………………….. HCTZ atenolol adalat xl hydrallazine
enalapril amlodipine other…………………….
 
Addendum B 
THE HYPERTENSIVE CRISIS PROJECT 
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